![Hans Rosén](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hans Rosén, who worked as the CEO of Artimplant AB in 2011, and as a Director at Bioretec Ltd. from 2018 to 2022.
| Unternehmen | Position | Ende |
|---|---|---|
| BIORETEC OY | Direktor/Vorstandsmitglied | 13.04.2022 |
Artimplant AB
 Artimplant AB Medical SpecialtiesHealth Technology Develops, produces and markets implants | Präsident | 04.05.2011 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 2 |
|---|---|
Artimplant AB
Artimplant AB Medical SpecialtiesHealth Technology Develops, produces and markets implants | Health Technology |
Bioretec Ltd.
 Bioretec Ltd. Medical SpecialtiesHealth Technology Markets, develops, and manufactures bioabsorbable, bioactive, and drug-releasing surgical implants for orthopedic for surgery | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
